EnsoData is a leading healthcare technology company that is revolutionizing the way diagnoses are made and treatments are decided. With the use of Artificial Intelligence (AI) and Machine Learning (ML), EnsoData is unlocking rapid, accurate, and affordable diagnoses of major health threats.
For the past eight years, EnsoData has been at the forefront of incorporating AI and ML technology in sleep medicine and healthcare as a whole. This has allowed us to tackle large-scale problems that have long been a challenge in diagnosis and treatment decision-making. Our primary solution, EnsoSleep, has received FDA clearance in 2017 and has since been expanded to include home sleep studies, a viewing and reporting platform, and a total sleep time measurement.
In 2024, EnsoData received FDA clearance for its latest AI algorithm, EnsoSleep PPG. This innovative technology converts pulse oximetry, a commonly used and FDA-cleared wearable technology, into a diagnostic tool for clinicians. This new clearance opens doors for clinicians to reach more patients and use more accessible and cost-effective tools through AI-driven analysis.
At EnsoData, we understand the importance of timely and accurate diagnoses in improving patient outcomes. That's why our suite of AI tools is designed to help clinicians reduce healthcare turnaround times and cut into patient backlogs. By streamlining the diagnosis process, we are ultimately improving the patient care journey and health outcomes.
EnsoData is proud to be at the forefront of using AI and ML to transform healthcare. We are committed to providing clinicians with the most advanced and efficient tools to make accurate diagnoses and improve patient care. With EnsoData, the future of healthcare is brighter than ever before.